Eastern hepatobilliary surgery hospital
Shanghai, Shanghai Municipality, 200438, China
NCT Number: NCT02727673
The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200438, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
Eastern Hepatobiliary Surgery Hospital
Other
A Prospective Randomized Trial on the Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01715402
Adenocarcinoma, Carcinoma
Amiens, France
View Trial DetailsNCT07386639
Adenocarcinoma, Carcinoma
View Trial DetailsNCT06358001
Adenocarcinoma, Autoimmune Diseases
Orange, California, United States
View Trial DetailsNCT04313868
Adenocarcinoma, Carcinoma
Makati City, Philippines
View Trial Details